158 related articles for article (PubMed ID: 36670471)
1. Enhancement of the haemostatic effect of platelets in the presence of high normal concentrations of von Willebrand factor for critically ill patients needing platelet transfusion-a protocol for the will-plate randomised controlled trial.
Herrmann G; Blum A; Bolliger D; Achermann R; Estermann A; Gebhard CE; Henn A; Huber J; Singh J; Todorov A; Zehnder T; Zellweger N; Buser A; Tsakiris DA; Hollinger A; Siegemund M
Trials; 2023 Jan; 24(1):47. PubMed ID: 36670471
[TBL] [Abstract][Full Text] [Related]
2. Study protocol for a prospective randomised double-blind placebo-controlled clinical trial investigating a Better Outcome with Melatonin compared to Placebo Administered to normalize sleep-wake cycle and treat hypoactive ICU Delirium: the Basel BOMP-AID study.
Hollinger A; von Felten S; Sutter R; Huber J; Tran F; Reinhold S; Abdelhamid S; Todorov A; Gebhard CE; Cajochen C; Steiner LA; Siegemund M
BMJ Open; 2020 Apr; 10(4):e034873. PubMed ID: 32354780
[TBL] [Abstract][Full Text] [Related]
3. Impact of Additional Administration of von Willebrand Factor Concentrates to Thrombocyte Transfusion in Perioperative Bleeding in Cardiac Surgery.
Ledergerber K; Hollinger A; Zimmermann S; Todorov A; Trutmann M; Gallachi L; Gschwandtner LA; Ryser LA; Gebhard CE; Bolliger D; Buser A; Tsakiris DA; Siegemund M
Transfus Med Hemother; 2024 Feb; 51(1):22-31. PubMed ID: 38314243
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
5. Comparison of propofol and dexmedetomidine infused overnight to treat hyperactive and mixed ICU delirium: a protocol for the Basel ProDex clinical trial.
Hollinger A; Ledergerber K; von Felten S; Sutter R; Rüegg S; Gantner L; Zimmermann S; Blum A; Steiner LA; Marsch S; Siegemund M
BMJ Open; 2017 Jul; 7(7):e015783. PubMed ID: 28710219
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures.
Huber J; Stanworth SJ; Doree C; Fortin PM; Trivella M; Brunskill SJ; Hopewell S; Wilkinson KL; Estcourt LJ
Cochrane Database Syst Rev; 2019 Nov; 11(11):CD012745. PubMed ID: 31778223
[TBL] [Abstract][Full Text] [Related]
7. Protocol for a multicentre, randomised, parallel-control, superiority trial comparing administration of clotting factor concentrates with a standard massive haemorrhage protocol in severely bleeding trauma patients: the FiiRST 2 trial (a 2020 EAST multicentre trial).
da Luz LT; Callum J; Beckett A; Hucke HP; Carroll J; Grewal D; Schwartz B; Peng H; Engels PT; Parry N; Petrosoniak A; Tien H; Nathens AB; Scales D; Karkouti K
BMJ Open; 2021 Sep; 11(9):e051003. PubMed ID: 34479938
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic platelet transfusions prior to surgery for people with a low platelet count.
Estcourt LJ; Malouf R; Doree C; Trivella M; Hopewell S; Birchall J
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD012779. PubMed ID: 30221749
[TBL] [Abstract][Full Text] [Related]
9. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
Trials; 2021 May; 22(1):342. PubMed ID: 34001174
[TBL] [Abstract][Full Text] [Related]
11. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
12. Hemostasis in patients with severe von Willebrand disease improves after normal platelet transfusion and normalizes with further correction of the plasma defect.
Castillo R; Escolar G; Monteagudo J; Aznar-Salatti J; Reverter JC; Ordinas A
Transfusion; 1997 Aug; 37(8):785-90. PubMed ID: 9280321
[TBL] [Abstract][Full Text] [Related]
13. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
14. Cryopreserved platelets compared with liquid-stored platelets for the treatment of surgical bleeding: protocol for two multicentre randomised controlled blinded non-inferiority trials (the CLIP-II and CLIPNZ-II trials).
Reade MC; Marks DC; Howe B; McGuinness S; Parke R; Navarra L; Charlewood R; Johnson L; McQuilten Z; ;
BMJ Open; 2022 Dec; 12(12):e068933. PubMed ID: 36600425
[TBL] [Abstract][Full Text] [Related]
15. Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study.
Heijdra JM; Al Arashi W; de Jager NCB; Cloesmeijer ME; Bukkems LH; Zwaan CM; Leebeek FWG; Mathôt RAA; Cnossen MH;
BMJ Open; 2022 Feb; 12(2):e049493. PubMed ID: 35168962
[TBL] [Abstract][Full Text] [Related]
16. Thromboelastometry versus standard coagulation tests versus restrictive protocol to guide blood transfusion prior to central venous catheterization in cirrhosis: study protocol for a randomized controlled trial.
Rocha LL; Pessoa CM; Neto AS; do Prado RR; Silva E; de Almeida MD; Correa TD;
Trials; 2017 Feb; 18(1):85. PubMed ID: 28241780
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of a novel VWF-containing FVIII concentrate, Wilate(®), in the prophylaxis and treatment of bleeding episodes in previously treated haemophilia A patients.
Klukowska A; Windyga J; Batorova A
Thromb Res; 2011 Mar; 127(3):247-53. PubMed ID: 21220152
[TBL] [Abstract][Full Text] [Related]
18. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
19. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
Drews RE
Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
[TBL] [Abstract][Full Text] [Related]
20. The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial.
Wikkelsoe AJ; Afshari A; Stensballe J; Langhoff-Roos J; Albrechtsen C; Ekelund K; Hanke G; Sharif HF; Mitchell AU; Svare J; Troelstrup A; Pedersen LM; Lauenborg J; Madsen MG; Bødker B; Møller AM
Trials; 2012 Jul; 13():110. PubMed ID: 22805300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
